Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

计划入组 22 人 · 首次发布于 2017 年 9 月 6 日

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

计划入组 27 人 · 首次发布于 2017 年 9 月 6 日

A Study of Cephalexin Capsules in Healthy Participants

计划入组 28 人 · 首次发布于 2014 年 4 月 25 日

IL17R inhibitor(Dompe Farmaceutici)

C5AR1 inhibitors(Dompe Farmaceutici)

TRPM8 antagonists(Dompe Farmaceutici SpA)

DOMPE' FARMACEUTICI SPA

Italy

Dompe Farmaceutici SpA

Italy

S.M. FARMACEUTICI SRL

Italy

Dompé Receives FDA Priority Voucher for Intranasal NGF Therapy Targeting NAION Vision Loss

ARDS Clinical Pipeline Expands with 50+ Companies Developing Novel Therapies

Engitix Secures €21 Million Series A Extension to Advance ECM-Targeted Cancer and Fibrosis Therapies